wyeth v teva pharmaceuticals/ | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for wyeth v teva pharmaceuticals/

Sort by

Viewing results 1‒16 of 16

Law
Top 10 individuals: winner’s mission to share medical data
...In 2015, he advised Mylan on a successful defence against a hostile bid by Teva Pharmaceuticals....
December 10, 2019
News in-depthUS & Canadian companies
Pfizer looks to bulk up in era of slimming down
...When Pfizer revealed its most recent mega-merger, the $68bn takeover of Wyeth in 2009, Jeffrey Kindler, then chief executive, hailed the deal as “a powerful opportunity to transform our industry”....
November 23, 2015
FT Live
Investing in America
Foreign companies as drivers of US growth, resilience and competitiveness
Tuesday, 10 DecemberHybrid Conference
News in-depthUS & Canadian companies
Pfizer-Allergan tie-up would mark M&A high point
...Allergan’s $40.5bn sale of its generic drugs unit to Teva of Israel reflected consolidation in the lowest-margin part of the industry....
November 22, 2015
US & Canadian companies
No end in sight to wave of pharma dealmaking
...Since the start of last year, pharmaceuticals companies have agreed $462bn of mergers and acquisitions — greater than the gross domestic product of Austria....
April 26, 2015
US & Canadian companies
Teva and Sun Pharma fined $2.15bn for patent breach
...Teva, which is based in Israel, will pay $1.6bn staggered over the coming 16 months....
June 12, 2013
Pharmaceuticals sector
Pfizer fined for decade of bribery
...Teva of Israel, the world’s largest generic drugs group, this week also announced it was in discussions over allegations of bribery in a number of Latin American countries....
August 7, 2012
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Law
Leading from the front
...Her work has included Cephalon’s $6.8bn acquisition by Teva Pharmaceutical Industries, and her innovative approach to Burger King’s acquisition by 3G Capital Management was ranked as “Standout” in last year...
November 29, 2012
LexUS & Canadian companies
Pfizer / Ratiopharm
...Aside from acquiring Wyeth, Pfizer has nearly gone ex-growth and will soon lose exclusivity on blockbusters Lipitor and Effexor....
March 3, 2010
Pharmaceuticals: Drug groups feel price pressure around the globe
...Even after Pfizer acquired Wyeth last year in the US, it has retained an appetite for acquisitions, with a recent bid for Ratiopharm of Germany, the generics company, although it ultimately lost out to Teva...
May 3, 2010
Lina SaigolEuropean banks
Pfizer could ease Deutsche Bank’s pain
...Unfortunately, the bank wasn’t willing to bid more than €2.8bn, compared with Teva of Israel which won with a knockout €3.6bn offer....
March 21, 2010
UK companies
Grandma knows best when it comes to drugs
...While Sudocrem and Bisodol can be bought over the counter, Wiltshire-based Alliance Pharmaceuticals, with annual revenue of £13m ($22m), is building a business model based on the acquisition of older pharmaceutical...
November 14, 2009
US & Canadian companies
Court intervenes over US lawsuits
...The court will decide whether to shield drugmakers from many costly patient lawsuits, agreeing to hear Wyeth v Levine, a case that tests whether companies are protected from liability when federal regulators...
January 19, 2008
On Wall StreetGold
Financials bring cheer on Wall Street
...Teva Pharmaceutical Industries gained 2.9 per cent to $46.48 after it raised its full-year earnings guidance....
December 24, 2007
Mergers & Acquisitions
Synergy springs from cultural revolution
...When Teva encountered resistance after acquiring Abic, then the second largest pharmaceutical company in Israel, its executives realised that a culturally sensitive integration approach was needed....
October 5, 2006
Global Economy
US antitrust watchdogs in clash over generics
...their blood-thinner Plavix; Shire and its Adderall XR hyperactivity drug; Kos and cholesterol drug Niaspan; and generic makers Barr, Teva and Apotex....
June 4, 2006
FT Live
Funding Biopharma Innovation
Strategies for investing in drug development and commercialization
Wednesday, 26 June345 Park Avenue South, New York, NY, USA
Work & Careers
The big defence challenge
...A US court of appeal ruled in favour of a patent challenge by Teva Pharmaceutical, an Israeli generic drugmaker, overturning a lower court ruling that upheld Merck’ s patent for the once-weekly dose of Fosamax...
April 20, 2005

Previous pagePage 1 of 1Next page